Lisly Chéry

664 total citations
22 papers, 478 citations indexed

About

Lisly Chéry is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Cancer Research. According to data from OpenAlex, Lisly Chéry has authored 22 papers receiving a total of 478 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Pulmonary and Respiratory Medicine, 8 papers in Molecular Biology and 7 papers in Cancer Research. Recurrent topics in Lisly Chéry's work include Prostate Cancer Treatment and Research (13 papers), Prostate Cancer Diagnosis and Treatment (5 papers) and Renal cell carcinoma treatment (4 papers). Lisly Chéry is often cited by papers focused on Prostate Cancer Treatment and Research (13 papers), Prostate Cancer Diagnosis and Treatment (5 papers) and Renal cell carcinoma treatment (4 papers). Lisly Chéry collaborates with scholars based in United States, Macao and Puerto Rico. Lisly Chéry's co-authors include Peter S. Nelson, Colm Morrissey, Robert L. Vessella, Paul H. Lange, Hung‐Ming Lam, Bruce Montgomery, Ilsa M. Coleman, Javed Siddiqui, Heather H. Cheng and Muneesh Tewari and has published in prestigious journals such as PLoS ONE, Cancer Research and Clinical Cancer Research.

In The Last Decade

Lisly Chéry

20 papers receiving 474 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lisly Chéry United States 8 261 227 219 117 58 22 478
Zhi‐Bin Ke China 14 260 1.0× 306 1.3× 213 1.0× 83 0.7× 90 1.6× 61 574
Verena Sailer Germany 12 283 1.1× 244 1.1× 150 0.7× 169 1.4× 41 0.7× 20 515
Ghada Kurban Canada 8 361 1.4× 147 0.6× 233 1.1× 80 0.7× 48 0.8× 9 518
Shuanghe Peng China 13 168 0.6× 197 0.9× 171 0.8× 150 1.3× 65 1.1× 23 379
Shengming Jin China 13 290 1.1× 165 0.7× 210 1.0× 74 0.6× 84 1.4× 32 481
Zhenchong Xiong China 12 224 0.9× 105 0.5× 206 0.9× 243 2.1× 44 0.8× 27 498
Ping-Li Sun South Korea 13 261 1.0× 316 1.4× 128 0.6× 227 1.9× 49 0.8× 17 531
Archana Anantharaman United States 10 231 0.9× 123 0.5× 210 1.0× 190 1.6× 61 1.1× 16 486
Cristina Niccoli Italy 11 156 0.6× 140 0.6× 129 0.6× 150 1.3× 72 1.2× 19 393
Mariangela Balistreri Italy 10 270 1.0× 89 0.4× 219 1.0× 124 1.1× 72 1.2× 15 487

Countries citing papers authored by Lisly Chéry

Since Specialization
Citations

This map shows the geographic impact of Lisly Chéry's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lisly Chéry with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lisly Chéry more than expected).

Fields of papers citing papers by Lisly Chéry

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lisly Chéry. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lisly Chéry. The network helps show where Lisly Chéry may publish in the future.

Co-authorship network of co-authors of Lisly Chéry

This figure shows the co-authorship network connecting the top 25 collaborators of Lisly Chéry. A scholar is included among the top collaborators of Lisly Chéry based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lisly Chéry. Lisly Chéry is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Pettaway, Curtis A., Louis L. Pisters, John W. Davis, et al.. (2025). Grade Group 1 Core Volume at Time of Biopsy Is Not Associated With Rate of Adverse Pathology at Radical Prostatectomy. JU Open Plus. 3(9).
2.
Fang, Andrew M., Daniel E. Frigo, Andrew W. Hahn, et al.. (2025). GLP-1 Agonist Use Among Men With Localized Prostate Cancer: A Narrative Review and Rationale for Prospective Clinical Trials. Urology. 201. 152–158. 1 indexed citations
3.
Fang, Andrew M., Justin R. Gregg, Lisly Chéry, et al.. (2024). Surgical Management and Considerations for Patients with Localized High-Risk Prostate Cancer. Current Treatment Options in Oncology. 25(1). 66–83. 1 indexed citations
4.
Gu, Jian, Lisly Chéry, Graciela M. Nogueras‐González, et al.. (2024). A west African ancestry‐associated SNP on 8q24 predicts a positive biopsy in African American men with suspected prostate cancer following PSA screening. The Prostate. 84(7). 694–705. 3 indexed citations
5.
Labbate, Craig, Patrick J. Hensley, Tanner Miest, et al.. (2022). Longitudinal GFR trends after neoadjuvant chemotherapy prior to nephroureterectomy for upper tract urothelial carcinoma. Urologic Oncology Seminars and Original Investigations. 40(10). 454.e17–454.e23. 2 indexed citations
6.
Chéry, Lisly, et al.. (2021). Contemporary outcomes following robotic prostatectomy for locally advanced and metastatic prostate cancer. Translational Andrology and Urology. 10(5). 2178–2187. 4 indexed citations
7.
Szklaruk, Janio, et al.. (2020). 18F-Fluciclovine Uptake in a Ureterocele. Clinical Nuclear Medicine. 46(1). e3–e5.
8.
Borregales, Leonardo D., Mehrad Adibi, Arun Z. Thomas, et al.. (2019). Predicting Adherent Perinephric Fat Using Preoperative Clinical and Radiological Factors in Patients Undergoing Partial Nephrectomy. European Urology Focus. 7(2). 397–403. 17 indexed citations
9.
Chéry, Lisly, Leonardo D. Borregales, Bryan Fellman, et al.. (2017). The Effects of Neoadjuvant Axitinib on Anthropometric Parameters in Patients With Locally Advanced Non-metastatic Renal Cell Carcinoma. Urology. 108. 114–121. 13 indexed citations
10.
Chéry, Lisly, José A. Karam, & Christopher G. Wood. (2016). Cytoreductive nephrectomy for metastatic renal cell carcinoma.. PubMed. 14(9). 696–703. 3 indexed citations
11.
Roudier, Martine P., Brian R. Winters, Ilsa M. Coleman, et al.. (2016). Characterizing the molecular features of ERG-positive tumors in primary and castration resistant prostate cancer. The Prostate. 76(9). 810–822. 39 indexed citations
12.
Zhang, Xiaotun, Ilsa M. Coleman, Lisha G. Brown, et al.. (2015). SRRM4 Expression and the Loss of REST Activity May Promote the Emergence of the Neuroendocrine Phenotype in Castration-Resistant Prostate Cancer. Clinical Cancer Research. 21(20). 4698–4708. 129 indexed citations
13.
Figler, Bradley D., Lisly Chéry, Jeffrey B. Friedrich, Hunter Wessells, & Bryan B. Voelzke. (2015). Limited Panniculectomy for Adult Buried Penis Repair. Plastic & Reconstructive Surgery. 136(5). 1090–1092. 16 indexed citations
14.
Chéry, Lisly & Atreya Dash. (2015). The Role of Postchemotherapy Surgery in Germ Cell Tumors. Urologic Clinics of North America. 42(3). 331–342. 11 indexed citations
15.
Chéry, Lisly, Hung‐Ming Lam, Ilsa M. Coleman, et al.. (2014). Characterization of single disseminated prostate cancer cells reveals tumor cell heterogeneity and identifies dormancy associated pathways. Oncotarget. 5(20). 9939–9951. 79 indexed citations
16.
Zhang, Xiaotun, Ilsa M. Coleman, Roger Coleman, et al.. (2014). Abstract 1989: SRRM4 and the loss of REST may promote the emergence of the neuroendocrine /neuronal phenotype in castration resistant prostate cancer. Cancer Research. 74(19_Supplement). 1989–1989. 1 indexed citations
17.
Cheng, Heather H., Patrick S. Mitchell, Evan M. Kroh, et al.. (2013). Circulating microRNA Profiling Identifies a Subset of Metastatic Prostate Cancer Patients with Evidence of Cancer-Associated Hypoxia. PLoS ONE. 8(7). e69239–e69239. 153 indexed citations
18.
Macleod, Liam C., et al.. (2013). 350 LOW DENSITY LIPOPROTINE (LDL) LEVEL BUT NOT STATIN USE IS ASSOCIATED WITH RECURRENCE OF PROSTATE CANCER AFTER PRIMARY TREATMENT. The Journal of Urology. 189(4S). 2 indexed citations
19.
Zhang, Xiaotun, Ilsa Coleman, Roger Coleman, et al.. (2013). Abstract 406: Characterizing the molecular features of the neuroendocrine phenotype in castration resistant prostate cancer.. Cancer Research. 73(8_Supplement). 406–406. 1 indexed citations
20.
Chéry, Lisly, Jonathan L. Wright, James M. Hotaling, et al.. (2012). 575 NSAID AND STATIN USE AND RISK OF RENAL CELL CARCINOMA. The Journal of Urology. 187(4S). 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Zhi‐Bin Ke Breakdown of academic impact, for papers by Verena Sailer Breakdown of academic impact, for papers by Ghada Kurban Breakdown of academic impact, for papers by Shuanghe Peng Breakdown of academic impact, for papers by Shengming Jin Breakdown of academic impact, for papers by Zhenchong Xiong Breakdown of academic impact, for papers by Ping-Li Sun Breakdown of academic impact, for papers by Archana Anantharaman Breakdown of academic impact, for papers by Cristina Niccoli Breakdown of academic impact, for papers by Mariangela Balistreri
Rankless by CCL
2026